Skip to main content

Table 2 Multivariate prognostic analysis for PFS and OS

From: Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program

  beta E.S. Signif. HR
PFS Myxoid LPS −0.544 0.284 0.056 0.580
  Line of treatment 0.272 0.117 0.020 1.312
OS Myxoid LPS −0.970 0.241 0.000 0.379
  Retroperitoneal STS −0.524 0.209 0.012 0.592